Literature DB >> 647383

Self-stimulation at the lateral hypothalamus and locus coeruleus after specific unilateral lesions of the dopamine system.

G F Koob, P J Fray, S D Iversen.   

Abstract

A group of rats was trained to press levers for electrical stimulation from bipolar electrodes aimed at the lateral hypothalamus (LH), and another group was trained to self-stimulate from electrodes in the locus coeruleus (LC). All rats in both groups were subjected to unilateral injections of 6-hydroxydopamine into the substantia nigra and midbrain ventral tegmentum. The lesions produced profound depletions of dopamine from the ipsilateral frontal cortex, nucleus accumbens/olfactory tubercle, and corpus striatum. Pretreatment with desmethylimipramine prevented loss of noradrenaline in excess of that caused by electrode implantation. The destruction of the dopamine projections produced a persistent and pronounced deficit in intracranial self-stimulation from ipsilateral electrodes in both the LH and LC groups, but only transient effects on self-stimulation from contralateral electrodes at these sites. These results suggest that an intact dopamine system is required for the expression of self-stimulation behaviour.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 647383     DOI: 10.1016/0006-8993(78)90222-6

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  2 in total

1.  Potentiation of brain stimulation reward by morphine: effects of neurokinin-1 receptor antagonism.

Authors:  J E Robinson; E W Fish; M C Krouse; A Thorsell; M Heilig; C J Malanga
Journal:  Psychopharmacology (Berl)       Date:  2011-09-10       Impact factor: 4.530

2.  Dissociation in effects of lesions of the nucleus accumbens core and shell on appetitive pavlovian approach behavior and the potentiation of conditioned reinforcement and locomotor activity by D-amphetamine.

Authors:  J A Parkinson; M C Olmstead; L H Burns; T W Robbins; B J Everitt
Journal:  J Neurosci       Date:  1999-03-15       Impact factor: 6.167

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.